Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
UFI | US
-0.20
-2.84%
Consumer Cyclical
Textile Manufacturing
30/06/2024
30/08/2024
6.83
7.07
7.07
6.74
Unifi Inc. together with its subsidiaries manufactures and sells recycled and synthetic products in the United States China Brazil and internationally. Its polyester products include partially oriented yarn textured solution and package dyed twisted beamed and draw wound yarns in virgin or recycled varieties; and nylon products comprise virgin or recycled textured solution dyed and spandex covered yarns. The company also provides recycled solutions made from pre-consumer and post-consumer waste such as plastic bottle flake made from polyester and polymer beads and staple fiber made from polyester or nylon. It offers recycled and synthetic products primarily to yarn manufacturers knitters and weavers that produce fabric for the apparel hosiery home furnishings automotive industrial and other end-use markets. The company sells its products through sales force and independent sales agents under the REPREVE brand. Unifi Inc. was incorporated in 1969 and is headquartered in Greensboro North Carolina.
View LessLow Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
High Short-term Volatility
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
107.5%1 month
79.2%3 months
53.6%6 months
53.9%-
57.80
0.48
0.53
0.30
-13.74
0.41
3.21
-4.21M
124.66M
124.66M
-
-0.33
-74.60
4.20
-16.15
5.05
1.53
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
2.43
Range1M
2.48
Range3M
2.48
Rel. volume
0.72
Price X volume
339.87K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
No data |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
CRDL | CRDL | Drug Manufacturers-Specialty & Generic | 1.94 | 135.57M | 3.19% | n/a | 1.07% |
LFCR | LFCR | Drug Manufacturers-Specialty & Generic | 4.38 | 135.21M | 14.81% | 19.08 | 241.85% |
Zomedica Pharmaceuticals Corp | ZOM | Drug Manufacturers-Specialty & Generic | 0.1289 | 128.64M | 1.90% | n/a | 1.10% |
Aceto Corporation | ACET | Drug Manufacturers-Specialty & Generic | 1.46 | 120.31M | -1.35% | n/a | 8.14% |
Veru Inc | VERU | Drug Manufacturers-Specialty & Generic | 0.8184 | 119.80M | 0.42% | n/a | 36.36% |
Assertio Therapeutics Inc | ASRT | Drug Manufacturers-Specialty & Generic | 1.18 | 112.50M | 1.72% | n/a | 30.76% |
INC Research Holdings Inc | INCR | Drug Manufacturers-Specialty & Generic | 2.27 | 103.45M | 1.79% | n/a | 41.98% |
Karyopharm Therapeutics Inc | KPTI | Drug Manufacturers-Specialty & Generic | 0.7602 | 94.78M | -1.38% | n/a | -148.05% |
Benitec Biopharma Limited | BNTC | Drug Manufacturers-Specialty & Generic | 9.245 | 93.25M | 2.15% | n/a | 3.08% |
Relmada Therapeutics Inc | RLMD | Drug Manufacturers-Specialty & Generic | 2.8 | 84.49M | 6.06% | n/a | 0.00% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -13.74 | - | - |
Ent. to Revenue | 0.41 | - | - |
PE Ratio | - | - | - |
Price to Book | 0.48 | - | - |
Dividend Yield | - | - | - |
Std. Deviation (3M) | 53.55 | - | - |
Debt to Equity | 0.53 | - | - |
Debt to Assets | 0.30 | - | - |
Market Cap | 124.66M | - | - |